Inventor
FORMAN STEPHEN J
US23 patents
Patents
23 patentsUS9914909B2Mar 13, 2018
Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
HOPE CITY21 citations93
US11197919B2Dec 14, 2021
Chimeric antigen receptors targeting HER2
HOPE CITY11 citations83
US10676717B2Jun 9, 2020
Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
HOPE CITY5 citations83
US10821161B2Nov 3, 2020
CS1 targeted chimeric antigen receptor-modified T cells
HOPE CITY4 citations82
US12161714B2Dec 10, 2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
HOPE CITY1 citations72
US11918606B2Mar 5, 2024
CD123-specific chimeric antigen receptor redirected t cells and methods of their use
HOPE CITY1 citations71
US11730797B2Aug 22, 2023
CS1 targeted chimeric antigen receptor-modified T cells
HOPE CITY3 citations71
US10660916B2May 26, 2020
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
HOPE CITY2 citations70
US11230577B2Jan 25, 2022
Chimeric antigen receptors containing a chlorotoxin domain
HOPE CITY3 citations65
US12497440B2Dec 16, 2025
CS1 targeted chimeric antigen receptor-modified T cells
HOPE CITY1 citations63
US12522667B2Jan 13, 2026
Chimeric antigen receptors (CARs) having mutations in the fc spacer region and methods for their use
HOPE CITY1 citations62
US12478672B2Nov 25, 2025
Use of triplex CMV vaccine in CAR T cell therapy
HOPE CITY0 citations62
US12115189B2Oct 15, 2024
T cells for expression of chimeric antigen receptors and other receptors
HOPE CITY0 citations62
US11744862B2Sep 5, 2023
CS1 targeted chimeric antigen receptor-modified T cells for treatment of AL amyloidosis
HOPE CITY0 citations61
US11701405B2Jul 18, 2023
Chimeric antigen receptors and methods for reducing toxicity
HOPE CITY1 citations61
US12565535B2Mar 3, 2026
Chimeric antigen receptors targeted to PSCA
HOPE CITY0 citations60
US12551557B2Feb 17, 2026
Targeted chimeric antigen receptor modified T cells for treatment of IL13RALPHA2 positive malignancies
HOPE CITY1 citations60
US12472233B2Nov 18, 2025
Administration of engineered T cells for treatment of cancers in the central nervous system
HOPE CITY0 citations60
US11466097B2Oct 11, 2022
Chimeric antigen receptors targeted to PSCA
HOPE CITY1 citations60
US12364724B2Jul 22, 2025
Oncolytic virus expressing a car T cell target and uses thereof
HOPE CITY0 citations57
US12545714B2Feb 10, 2026
BAFF-R/CD19 targeted chimeric antigen receptor-modified T cells and use thereof
HOPE CITY0 citations56
US12496338B2Dec 16, 2025
CAR for treatment of HIV infection
HOPE CITY0 citations56
US12281152B2Apr 22, 2025
TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumors
HOPE CITY1 citations56